服務熱線
400-611-2850
 |
百替生物
百替生物創立于2011年，專注于重大疾病診療新產品新技術的轉化研究和研發，聚焦納米醫藥技術，包括納米載藥技術、通用納米晶技術、膜囊泡載藥技術、腫瘤個體化納米疫苗技術等，為腫瘤、心血管和炎癥等疾病方向的研究組織和機構提供臨床轉化和研發支持。平臺齊備納米藥物設計、合成、表征，藥理藥效、體內外生物學評價和機制研究等實驗室，可快速產出重大疾病診療創新醫藥技術成果；擁有生產和銷售數萬種轉化醫學研究實驗相關試劑耗材的資質，和頂級研究型三甲醫院1100多個專家組深度合作，可保障轉化和研發項目的高效實施。
百替生物通過AAA級信用企業認證、ISO9001質量管理體系認證和ISO27001信息安全管理體系認證，項目實施管理采用高效智能科研ERP系統，符合GLP、GMP和GCP標準，并嚴格遵循醫學研究規范和倫理。
近十年的積累與發展，百替生物作為研究轉化平臺，為研究者、醫健企業提供研究轉化所需的技術支持，擁有多條新藥研發管線，并設有“普略醫學研究院”。百替生物一直以“一個研究院+一個轉化平臺+多個研發管線”的模式高效運轉，為醫療健康領域的進步貢獻力量，秉承“引領醫學科研，提升人類健康”、“攻克重大疾病”的愿景和使命，為社會創造轉化醫學價值。
|
|
ntroduction to 100Biotech technologies (HangZhou) Co., Ltd.
100Biotech was founded in 2011, which concentrates on translational research of new products and technologies for major disease’s diagnosis and treatments. It focuses on nanomedicine technology, exosomes, and novel RNA to provide translational medicine research for the research organizations and institutions in the field of tumors, cardiovascular, inflammation and so on. It is fully equipped with laboratories for design, synthesis, and characterization of nanodrugs, isolation, identification and detection of exosomes, screening, characterization, and generation mechanism analysis of novel RNA, in vitro and in vivo biological evaluation and mechanism research, which can produce innovative results quickly. It has qualification of producing and selling tens of thousands of medical reagents and consumables to efficiently guarantee the implementation of research and development. |
 |
|
100Biotech is a AAA credit enterprise, which has passed ISO9001 quality management system certification and ISO27001 information security management system certification. 100Biotech conforms to GLP, GMP and GCP standards, and follows the medical research norms and ethics strictly, while the project management adopts the efficient and intelligent ERP system.
Undergoing ten years accumulating and development, 100Biotech as a research and transformation platform, provides researchers and medical enterprises with the technical supports for translational research, which has multiple new drug research and development pipelines, and set up "100Biotech Medicine Research Institute". 100Biotech runs efficiently with the model of "one research institute + one transformation platform + multiple research and development pipelines", contributes to the advances of healthcare. 100Biotech will take the vision of “Leading Medical Research, Improving Human Health” and the mission of “Conquer Major Diseases”， to create translational medical value for the society. |
|
